INVISIX LANDS €20M SEED FOR CHIPMAKING MEASUREMENT TECH

AI DESK■ 1 MIN READ

WED, JUN 3, 2026

■ AI-SUMMARIZED FROM 2 SOURCES ▸ TIMELINE

Netherlands-based Invisix has raised €20 million in seed funding to advance its advanced metrology tools for semiconductor manufacturing. A tier-one chipmaker participated in the round.

Invisix has developed a soft x-ray metrology solution grounded in Nobel Prize-winning research. The technology is designed to address critical measurement challenges in chip production as semiconductor geometries shrink. The seed round demonstrates investor confidence in specialized tools serving the semiconductor industry. The participation of a major chipmaker signals validation from within the sector. Invisix joins a wave of European semiconductor infrastructure companies attracting capital. Related funding includes French quantum computing startup Quobly's €115 million Series A round, backed by Bpifrance, SEALSQ, and STMicro. Advanced metrology is essential as chipmakers push toward smaller process nodes. Measurement accuracy directly impacts yield and production efficiency.

■ SOURCES

► Techmeme ► Techmeme

■ SUMMARY WRITTEN BY AI FROM THE LINKS ABOVE

■ MORE FROM THE STARTUPS DESK

P414ENVEDA RAISES $311M AT $2B VALUATION

Colorado-based biotech startup Enveda, which uses AI to discover new drugs from natural sources, secured $311 million in Series E funding at a $2 billion valuation—double its valuation from a year ago.

2H AGO— AI Desk

P402AI INFRASTRUCTURE STARTUPS MODAL, BASETEN RAISE FUNDING

Modal Labs and Baseten, two platforms enabling businesses to run AI models, are in advanced funding talks that would significantly boost their valuations. The rounds reflect growing investor appetite for AI infrastructure services.

4H AGO— AI Desk

P395EMA RAISES $77M SERIES B FOR AI PROCESS AUTOMATION

Ema, an AI agent platform automating corporate processes in HR, IT, and finance, secured $77 million in Series B funding led by Creaegis. The round brings the startup's total funding to $140 million.

6H AGO— AI Desk

P385ENVEDA LANDS $311M FOR NATURE-BASED AI DRUG TRIALS

Enveda Therapeutics raised $311 million in funding, bringing the AI biotech company's valuation to $2 billion. The capital will accelerate clinical trials for drugs derived from natural compounds.

7H AGO— AI Desk

◄ BACK TO NEWS

INVISIX LANDS €20M SEED FOR CHIPMAKING MEASUREMENT TECH

■ MORE FROM THE STARTUPS DESK

■ SUBSCRIBE TO THE DAILY BRIEF